{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:18:13Z","timestamp":1773803893446,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018741","name":"Tosoh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.chroma.2025.466319","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T23:39:33Z","timestamp":1756165173000},"page":"466319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Preparative choline-based anion-exchange chromatography for enrichment of full adeno-associated virus capsids"],"prefix":"10.1016","volume":"1760","author":[{"given":"Yuliya","family":"McAnany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8385-4446","authenticated-orcid":false,"given":"Leila","family":"Bonakdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Bouskila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2324-6452","authenticated-orcid":false,"given":"Tianyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4649-7389","authenticated-orcid":false,"given":"Danielle","family":"Baun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Makino-Manabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egbert","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-0303","authenticated-orcid":false,"given":"Romain","family":"Dabre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Kervinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2025.466319_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.04.004","article-title":"Gene regulation technologies for gene and cell therapy","author":"Butterfield","year":"2025","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.chroma.2025.466319_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/v17020239","article-title":"Adeno-associated virus vectors: principles, practices, and prospects in gene therapy","volume":"17","author":"Zwi-Dantsis","year":"2025","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.chroma.2025.466319_bib0003","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.3390\/cimb46080499","article-title":"Therapeutic application and structural features of Adeno-associated virus vector","volume":"46","author":"Matsuzaka","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.chroma.2025.466319_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.03.056","article-title":"Advances in AAV capsid engineering: integrating rational design, directed evolution and machine learning","author":"Nisanov","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13036-024-00409-4","article-title":"Advanced biomanufacturing and evaluation of adeno-associated virus","volume":"18","author":"Chen","year":"2024","journal-title":"J. Biol. Eng."},{"issue":"3\u20134","key":"10.1016\/j.chroma.2025.466319_bib0006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/hum.2024.160","article-title":"Production of recombinant adeno-associated virus through high-cell-density transfection of HEK293 cells based on fed-perfusion culture","volume":"36","author":"Deng","year":"2025","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.chroma.2025.466319_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101228","article-title":"A robust and flexible baculovirus-insect cell system for AAV vector production with improved yield, capsid ratios and potency","volume":"32","author":"Marwidi","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"3","key":"10.1016\/j.chroma.2025.466319_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/v16030442","article-title":"Natural adeno-associated virus serotypes and engineered adeno-associated virus capsid variants: tropism differences and mechanistic insights","volume":"16","author":"Lopez-Gordo","year":"2024","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.chroma.2025.466319_bib0009","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: the Rubik's cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.chroma.2025.466319_bib0010","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ymthe.2025.01.041","article-title":"A comprehensive atlas of AAV tropism in the mouse","volume":"33","author":"Walkey","year":"2025","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.chroma.2025.466319_bib0011","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41587-020-00793-4","article-title":"Deep diversification of an AAV capsid protein by machine learning","volume":"39","author":"Bryant","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chroma.2025.466319_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-025-00524-x","article-title":"Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical application","author":"Mehta","year":"2025","journal-title":"Gene. Ther."},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400526","article-title":"Towards a platform chromatography purification process for adeno-associated virus (AAV)","volume":"20","author":"Bogdanovic","year":"2025","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.chroma.2025.466319_bib0015","series-title":"National Library of Medicine","year":"2025"},{"issue":"6","key":"10.1016\/j.chroma.2025.466319_bib0016","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.tibtech.2022.11.006","article-title":"Evading and overcoming AAV neutralization in gene therapy","volume":"41","author":"Earley","year":"2023","journal-title":"Trends Biotechnol."},{"issue":"4","key":"10.1016\/j.chroma.2025.466319_bib0017","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ymthe.2022.03.004","article-title":"Durability of transgene expression after rAAV gene therapy","volume":"30","author":"Muhuri","year":"2022","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.chroma.2025.466319_bib0018","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/bit.28932","article-title":"Chromatography in downstream processing of recombinant adeno-associated viruses: a review of current and future practises","volume":"122","author":"Lorek","year":"2025","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2025.466319_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2025.02.016","article-title":"Process and quality considerations for recombinant adeno-associated virus manufacturing platforms","author":"Park","year":"2025","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.chroma.2025.466319_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.chroma.2025.466319_bib0021","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.ymthe.2025.03.037","article-title":"The curious case of AAV immunology","volume":"33","author":"Keeler","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41598-024-84077-w","article-title":"Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy","volume":"15","author":"Potter","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2025.466319_bib0023","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fmicb.2011.00194","article-title":"Innate immune responses to AAV vectors","volume":"2","author":"Rogers","year":"2011","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.chroma.2025.466319_bib0024","article-title":"Empty virions In AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side-effects","volume":"1","author":"Gao","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.466319_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Clement","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0026","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/biomedicines2010080","article-title":"Product-related impurities in clinical-grade recombinant AAV vectors: characterization and risk assessment","volume":"2","author":"Wright","year":"2014","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.chroma.2025.466319_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101441","article-title":"A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors","volume":"33","author":"Thakur","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.466319_bib0028","series-title":"U.S. Department of Health & Human Services, Food and Drug Administration","year":"2023"},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1208\/s12248-022-00768-0","article-title":"ACUVRA: anion-exchange chromatography UV-ratio analysis-A QC-friendly method for monitoring adeno-associated virus empty capsid content to support process development and GMP release testing","volume":"25","author":"Frenkel","year":"2022","journal-title":"AAPS. J."},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1525-0016(02)00019-9","article-title":"Quantification of adeno-associated virus particles and empty capsids by optical density measurement","volume":"7","author":"Sommer","year":"2003","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.chroma.2025.466319_bib0031","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1002\/bit.27905","article-title":"Assessment of quality attributes for adeno-associated viral vectors","volume":"118","author":"Tustian","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.chroma.2025.466319_bib0032","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.omtm.2021.02.010","article-title":"Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies","volume":"20","author":"Gimpel","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.466319_bib0033","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejpb.2023.05.011","article-title":"Purity and DNA content of AAV capsids assessed by analytical ultracentrifugation and orthogonal biophysical techniques","volume":"189","author":"Richter","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"42","key":"10.1016\/j.chroma.2025.466319_bib0034","doi-asserted-by":"crossref","first-page":"17037","DOI":"10.1021\/acs.analchem.4c05229","article-title":"Multimass analysis of adeno-associated virus vectors by orbitrap-based charge detection mass spectrometry","volume":"96","author":"Nakatsuka","year":"2024","journal-title":"Anal. Chem."},{"issue":"20","key":"10.1016\/j.chroma.2025.466319_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012332","article-title":"Anion-exchange chromatography at the service of gene therapy: baseline separation of full\/empty adeno-associated virus capsids by screening of conditions and step gradient elution mode","volume":"23","author":"Aebischer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21\u201322","key":"10.1016\/j.chroma.2025.466319_bib0036","first-page":"1390","article-title":"Development and validation of an anion exchange high-performance liquid chromatography method for analysis of empty capsids and capsids encapsidating genetic material in a purified preparation of recombinant Adeno-Associated Virus serotype 5","volume":"32","author":"Joshi","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.chroma.2025.466319_bib0037","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.omtm.2021.04.003","article-title":"Anion-exchange HPLC assay for separation and quantification of empty and full capsids in multiple adeno-associated virus serotypes","volume":"21","author":"Khatwani","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.466319_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2023.115421","article-title":"Separation of full and empty adeno-associated virus capsids by anion-exchange chromatography using choline-type salts","volume":"686","author":"Kurth","year":"2024","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2025.466319_bib0039","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.omtm.2019.09.006","article-title":"Developing an Anion exchange chromatography assay for determining empty and full capsid contents in AAV6.2","volume":"15","author":"Wang","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0040","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1038\/s41598-021-82599-1","article-title":"Comprehensive characterization and quantification of adeno associated vectors by size exclusion chromatography and multi angle light scattering","volume":"11","author":"McIntosh","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.chroma.2025.466319_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101382","article-title":"Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus","volume":"32","author":"Mulagapati","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"7\u20138","key":"10.1016\/j.chroma.2025.466319_bib0042","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/hum.2022.218","article-title":"Application of size exclusion chromatography with multiangle light scattering in the analytical development of a preclinical stage gene therapy program","volume":"34","author":"Troxell","year":"2023","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.chroma.2025.466319_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101293","article-title":"Probing recombinant AAV capsid integrity and genome release after thermal stress by mass photometry","volume":"32","author":"Ebberink","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"2","key":"10.1016\/j.chroma.2025.466319_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020361","article-title":"Consecutive affinity and ion-exchange chromatography for AAV9 vectors purification","volume":"13","author":"Duzenli","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.chroma.2025.466319_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465586","article-title":"Purification of AAV8 through a scalable two-step monolithic chromatography approach","volume":"1740","author":"Nascimento","year":"2025","journal-title":"J. Chromatogr. A"},{"issue":"5","key":"10.1016\/j.chroma.2025.466319_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050748","article-title":"Comparison of different liquid chromatography-based purification strategies for adeno-associated virus vectors","volume":"13","author":"Rieser","year":"2021","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.chroma.2025.466319_bib0047","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1128\/JVI.02524-12","article-title":"Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking","volume":"87","author":"Venkatakrishnan","year":"2013","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.chroma.2025.466319_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000025","article-title":"Production, processing, and characterization of synthetic AAV gene therapy vectors","volume":"16","author":"El Andari","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.chroma.2025.466319_bib0049","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.omtm.2021.03.016","article-title":"Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9","volume":"21","author":"Joshi","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.466319_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464632","article-title":"Rational downstream development for adeno-associated virus full\/empty capsid separation - A streamlined methodology based on high-throughput screening and mechanistic modeling","volume":"1716","author":"Keller","year":"2024","journal-title":"J. Chromatogr. A"},{"issue":"4","key":"10.1016\/j.chroma.2025.466319_bib0051","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.chroma.2025.466319_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2025.133051","article-title":"Downstream processing of AAV based gene therapy vectors","volume":"368","author":"Jungbauer","year":"2025","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.chroma.2025.466319_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465320","article-title":"Serotype-agnostic affinity purification of adeno-associated virus (AAV) via peptide-functionalized chromatographic resins","volume":"1734","author":"Shastry","year":"2024","journal-title":"J. Chromatogr. A"},{"issue":"7\u20138","key":"10.1016\/j.chroma.2025.466319_bib0054","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41434-023-00398-x","article-title":"Large-scale purification of functional AAV particles packaging the full genome using short-term ultracentrifugation with a zonal rotor","volume":"30","author":"Wada","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.chroma.2025.466319_bib0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.omtm.2021.08.009","article-title":"Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors","volume":"23","author":"Werle","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"2","key":"10.1016\/j.chroma.2025.466319_bib0056","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11095-018-2554-7","article-title":"Pharmaceutical development of AAV-based gene therapy products for the eye","volume":"36","author":"Rodrigues","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chroma.2025.466319_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2022.114598","article-title":"Optimized formulation buffer preserves adeno-associated virus-9 infectivity after 4 degrees C storage and freeze\/thawing cycling","volume":"309","author":"Chan","year":"2022","journal-title":"J. Virol. Methods"},{"issue":"5","key":"10.1016\/j.chroma.2025.466319_bib0058","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.xphs.2022.01.002","article-title":"Impact of time out of intended storage and freeze-thaw rates on the stability of adeno-associated virus 8 and 9","volume":"111","author":"Bee","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2025.466319_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101112","article-title":"Adeno-associated viral capsid stability on anion exchange chromatography column and its impact on empty and full capsid separation","volume":"31","author":"Khanal","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"4","key":"10.1016\/j.chroma.2025.466319_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/hgtb.2015.051","article-title":"Comparative analysis of cesium chloride- and iodixanol-based purification of recombinant adeno-associated viral vectors for preclinical applications","volume":"26","author":"Strobel","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"issue":"3","key":"10.1016\/j.chroma.2025.466319_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101309","article-title":"Characterization of AAV vectors: a review of analytical techniques and critical quality attributes","volume":"32","author":"Kontogiannis","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.466319_bib0062","doi-asserted-by":"crossref","DOI":"10.2174\/0115665232369708250327081305","article-title":"Imaged capillary isoelectric focusing (icIEF) platform for characterization of charge variants of adeno-associated virus (AAV) capsids and impact on their transduction efficiency","author":"Hoyle","year":"2025","journal-title":"Curr. Gene Ther."},{"issue":"2","key":"10.1016\/j.chroma.2025.466319_bib0063","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.xphs.2024.11.005","article-title":"Limitation of anion exchange chromatography and potential application of hydrophobic interaction chromatography for monitoring AAV9 capsid degradation upon thermal stress","volume":"114","author":"Rodriguez","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2025.466319_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116452","article-title":"Distinct chemical degradation pathways of AAV1 and AAV8 under thermal stress conditions revealed by analytical anion exchange chromatography and LC-MS-based peptide mapping","volume":"251","author":"Xing","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.466319_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465550","article-title":"Modeling indirectly detected analyte peaks in ion-pair reversed-phase chromatography","volume":"1740","author":"Lesko","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.466319_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465574","article-title":"Evaluation of ion pairing reversed-phase liquid chromatography for the separation of large RNA molecules","volume":"1740","author":"Maurer","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.466319_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465672","article-title":"Ion exchange chromatography of biotherapeutics: fundamental principles and advanced approaches","volume":"1742","author":"Imiolek","year":"2025","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325006636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325006636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:56:57Z","timestamp":1772819817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967325006636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":66,"alternative-id":["S0021967325006636"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2025.466319","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparative choline-based anion-exchange chromatography for enrichment of full adeno-associated virus capsids","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2025.466319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Tosoh Bioscience LLC. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"466319"}}